Concepedia

Karen M. Yates

KM

3

Publications

306

Citations

3

H-Index

2006

Active since

Affiliations

Pfizer (United States)(Current)

Karen M. Yates is an author at Pfizer (United States) specializing in drug discovery, pharmacotherapy, and medicine.

Top concepts

Publications per year

2006–2007

3

Publications

3

Discovery of<i>N</i>-[(3<i>R</i>)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-<i>c</i>]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia:  Synthesis and Structure−Activity Relationship

Donn G. Wishka, Daniel P. Walker, Karen M. Yates et al. · Journal of Medicinal Chemistry · 2006 · 188 citations · Full text

, , +23

Design, synthesis, structure–activity relationship, and in vivo activity of azabicyclic aryl amides as α7 nicotinic acetylcholine receptor agonists

Daniel P. Walker, Donn G. Wishka, David W. Piotrowski et al. · Bioorganic & Medicinal Chemistry · 2006 · 94 citations

, , +8

N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain

Christopher Deur, Arun K. Agrawal, Heidi Baum et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 24 citations · Full text

, , +12

Rows per page

1–3 of 3